Yıldız ÖZALP
(Near East University Faculty of Pharmacy, Department of Pharmaceutical Technology, Nicosia, Cypus)
Joseph Turemi CHUNU
(Near East University Faculty of Pharmacy, Department of Pharmaceutical Technology, Nicosia, Cypus)
Nailla JIWA
(Near East University Faculty of Pharmacy, Department of Pharmaceutical Technology, Nicosia, Cypus)
Yıl: 2020Cilt: 17Sayı: 3ISSN: 1304-530X / 2148-6247Sayfa Aralığı: 249 - 253İngilizce

47 0
Investigation of the Compressibility Characteristics of Paracetamol using “Compaction Simulator”
Objectives: This study was performed to understand the behavior of poorly compressible paracetamol powder using a compaction simulator (CS), equipment that records data during the compaction process. The aim was to investigate the compressibility of paracetamol tablets using a dry granulation (slugging) process, with different formulation compositions. Materials and Methods: Formulations were prepared to observe the effect on compressibility with two different lactose-based fillers, Flowlac®100 and Granulac®70, and a binder, Kollidon® K90. In each combination, a total of four formulations were prepared with paracetamol to filler ratios of 1:1 and 0.8:1. Tablets were produced by single punch (11.28 mm) CS at six different pressures (152, 210, 263, 316, 400, and 452 MPa). During compression, upper punch displacement and force data were produced by the CS equipment. The compressed tablets were tested for hardness, thickness, and weight variation and compared with each other. Results: All formulations reached maximum tensile strength at compaction pressures between 263 and 316 MPa. In the formulations without binder, those containing Granulac®70 had higher tensile strength than those containing Flowlac®100 at both filler ratios. The results obtained indicated that the addition of binder to the formulations (F-45-1, F-45-2, F-50-3, and F-50-4) improved the compressibility of paracetamol. Formulation F-45-2, containing Flowlac®100 and binder, showed better compressibility at 2.9 MPa tensile strength. Data from the CS were used to compare Young’s modulus and work of compaction on selected formulations (F-45-1 and F-45-2). Conclusion: The proposed lactose-based filler, Flowlac®100, with low pressure can be successfully applied for improving the compressibility of paracetamol. An optimum formulation can be designed with smaller amounts of materials using a compaction simulator.
DergiAraştırma MakalesiErişime Açık
  • 1. Sun CC, Kleinebudde P. Mini review: Mechanisms to the loss of tabletability by dry granulation. Eur J Pharm Biopharm. 2016;106:9-14.
  • 2. Mosig J, Kleinebudde P. Critical evaluation of root causes of the reduced compactability after roll compaction/dry granulation. J Pharm Sci. 2015;104:1108-1118.
  • 3. Herting MG, Kleinebudde P. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties. Int J Pharm. 2007;338:110-118.
  • 4. Kochhar SK, Rubinstein MH, Barnes D. The effects of slugging and recompression on pharmaceutical excipients. Int J Pharm. 1995;115:35-43.
  • 5. Herting MG, Kleinebudde P. Studies on the reduction of tensile strength of tablets after roll compaction/dry granulation. Eur J Pharm Biopharm. 2008;70:372-379.
  • 6. Bozic DZ, Dreu R, Vrecer F. Influence of dry granulation on compactibility and capping tendency of macrolide antibiotic formulation. Int J Pharm. 2008;357:44-54.
  • 7. Wu CY, Ruddy OM, Bentham AC, Hancock BC, Best SM, Elliott JA. Modelling the mechanical behaviour of pharmaceutical powders during compaction. Powder Technology. 2005;152:107-117.
  • 8. Freitag F, Kleinebudde P. How do roll compaction/dry granulation affect the tableting behaviour of inorganic materials? Comparison of four magnesium carbonates. Eur J Pharm Sci. 2003;19:281-289.
  • 9. Sun CC. Dependence of ejection force on tableting speed-A compaction simulation study. Powder Technology. 2015;279:123-126.
  • 10. Çelik M. Overview of compaction data analysis techniques. Drug Dev Ind Pharm. 1992;18:767-810.
  • 11. Çelik M, Marshall K. Use of a compaction simulator system in tabletting research. Drug Dev Ind Pharm. 1989;15:759-800.
  • 12. Kawashima Y, Takeuchi H, Hino T, Niwa T, Lin TL, Sekigawa F, Kawahara K. Preparation of a sustained-release matrix tablet of acetaminophen with pulverized low-substituted hydroxypropylcellulose via dry granulation. Chemical Pharm Bull (Tokyo). 1993;41:1827-1831.
  • 13. Khan KA, Musikabhumma P. Effect of slugging pressure on the properties of granules and tablets prepared from potassium phenethicillin. J Pharm Pharmacol. 1981;33:627-631.
  • 14. Jain S. Mechanical properties of powders for compaction and tableting: an overview. Pharm Sci Technolo Today. 1999;2:20-31.
  • 15. Sun CC, Himmelspach MW. Reduced tabletability of roller compacted granules as a result of granule size enlargement. J Pharm Sci. 2006;95:200-206.
  • 16. Haware RV, Tho I, Bauer-Brandl A. Multivariate analysis of relationships between material properties, process parameters and tablet tensile strength for α-lactose monohydrates. Eur J Pharm Biopharm. 2009;73:424-431.
  • 17. Boschini F, Delaval V, Traina K, Vandewalle N, Lumay G. Linking flowability and granulometry of lactose powders. Int J Pharm. 2015;494:312-320.
  • 18. Kadiri MS, Michrafy A. The effect of punch’s shape on die compaction of pharmaceutical powders. Powder Technology. 2013;239:467-477.
  • 19. Michrafy A, Ringenbacher D, Tchoreloff P. Modelling the compaction behaviour of powders: application to pharmaceutical powders. Powder Technology. 2002;127:257-266.
  • 20. Michrafy A, Dodds JA, Kadiri MS. Wall friction in the compaction of pharmaceutical powders: measurement and effect on the density distribution. Powder Technology. 2004;148:53-55.
  • 21. Han LH, Elliott JA, Bentham AC, Mills A, Amidon GE, Hancock BC. A modified Drucker-Prager Cap model for die compaction simulation of pharmaceutical powders. Int J Solids Struct. 2008;45:3088-3106.
  • 22. Malamataris S, Hatjichristos T, Rees JE. Apparent compressive elastic modulus and strength isotropy of compacts formed from binary powder mixes. Int J Pharm. 1996;141:101-108.
  • 23. Vromans H, Bolhuis GK, Lerk CF, Van de Biggelaar H, Bosch H. Studies on tableting properties of lactose. VII. The effect of variations in primary particle size and percentage of amorphous lactose in spray dried lactose products. Int J Pharm. 1987;35:29-37.
  • 24. Krycer I, Pope DG, Hersey JA. An evaluation of the techniques employed to investigate powder compaction behaviour. Int J Pharm. 1982;12:113- 134.
  • 25. Fell JT, Newton JM. Assessment of compression characteristics of powders. J Pharm Sci. 1971;60:1428-1429.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.